NCT01448538View on ClinicalTrials.gov

Non-Persistence/Non-Adherence (NP/NA) in Wet Age-related Macular Degeneration (wAMD) Patients in Germany

CompletedOBSERVATIONAL
Enrollment

480

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

February 28, 2014

Conditions
Wet Macular Degeneration
Interventions
DRUG

Anti-VEGF injections

All Anti-VEGF injections approved for the German market, dosages as defined by doctors

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY